[go: up one dir, main page]

KR20030086849A - A composition for whitening containing crown daisy extract - Google Patents

A composition for whitening containing crown daisy extract Download PDF

Info

Publication number
KR20030086849A
KR20030086849A KR1020020025045A KR20020025045A KR20030086849A KR 20030086849 A KR20030086849 A KR 20030086849A KR 1020020025045 A KR1020020025045 A KR 1020020025045A KR 20020025045 A KR20020025045 A KR 20020025045A KR 20030086849 A KR20030086849 A KR 20030086849A
Authority
KR
South Korea
Prior art keywords
extract
mugwort
melanin
whitening
weight
Prior art date
Application number
KR1020020025045A
Other languages
Korean (ko)
Inventor
강원형
한영숙
정은선
Original Assignee
메디코룩스(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메디코룩스(주) filed Critical 메디코룩스(주)
Priority to KR1020020025045A priority Critical patent/KR20030086849A/en
Publication of KR20030086849A publication Critical patent/KR20030086849A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a composition for skin whitening which contains a Chrysanthemum coronarium L. extract, as natural skin whitening material, selected from freeze-dried extract, hot water extract or ethanol extract. CONSTITUTION: A composition for skin whitening characteristically contains 0.01-10 wt.% of one or more kinds of Chrysanthemum coronarium L. extracts, as an active ingredient, selected from the group consisting of freeze-dried extract, hot water extract or ethanol extract. It inhibits tyrosinase activity to decrease the generation of melanin, and has extended storage.

Description

쑥갓 추출물을 함유하는 미백조성물{A composition for whitening containing crown daisy extract}Whitening composition containing wormwood extract {A composition for whitening containing crown daisy extract}

본 발명은 쑥갓 추출물을 함유하는 미백조성물에 관한 것으로, 좀더 상세하게는 천연 미백소재인 쑥갓의 냉동건조 분말, 열수 추출물 또는 에탄올 추출물을 함유하는 미백조성물에 관한 것이다.The present invention relates to a whitening composition containing mugwort extract, and more particularly to a whitening composition containing a freeze-dried powder, hot water extract or ethanol extract of mugwort, which is a natural whitening material.

쑥갓(Chrysanthemum coronariumL.)은 원산지인 유럽으로부터 동아시아에 전파되어 채소로 이용된 것으로 현재 채소로 이용되고 있는 지역은 인도, 동남아시아전역, 중국, 한국, 일본 등으로서, 쑥갓은 단백질 2%, 탄수화물 2~3%, 지방 0.3%, 섬유 0.9%, 회분 1.5%를 함유하고 있다.Wormwood chrysanthemum ( Chrysanthemum coronarium L.) spread from East of origin to East Asia and used as vegetables. Regions currently used as vegetables are India, Southeast Asia, China, Korea, Japan, etc. ˜3%, fat 0.3%, fiber 0.9%, ash 1.5%.

쑥갓의 비타민 함량은 쑥갓 100g에 대해서 비타민 A 6,000 I.U., 비타민 B1 100r, 비타민 B2 60r, 비타민 C 60mg 으로서 매우 많은 편이고, 홍당무 등에 다량 함유되어 있는 카로틴(carotene) 및 미네랄로서 칼슘을 함유하고 있는 것도 특징이라 할 수 있으며, 필수 아미노산인 라이신(lysine)을 다량으로 함유하고 있다.The content of vitamins in mugwort is 6,000 IU, vitamin B1 100r, vitamin B2 60r, and vitamin C 60mg per 100g of mugwort, and it also contains calcium as carotene and mineral which are contained in blush, etc. It can be said that it contains a large amount of lysine (lysine), an essential amino acid.

인체의 피부색은 햇빛을 받으면 검게 변하게 되는데, 이러한 원인은 검은 색소의 일종인 멜라닌(melanin)이 인체에 형성되기 때문으로, 멜라닌은 동물, 식물 및 미생물에 널리 존재하는 페놀류(phenols)의 고분자 물질로서 검은 색소와 단백질로 이루어져 있다.The skin color of the human body turns black when it is exposed to sunlight. This is because melanin (melanin), a kind of black pigment, is formed in the human body. It consists of black pigment and protein.

멜라닌은 멜라닌 형성세포 내의 타이로신(tyrosine)을 기질로 하여 타이로시나제(tyrosinase)가 작용하여 도파퀴논(dopaquinone)이 생성되고 이 도파퀴논이 산화반응 및 효소반응을 거쳐 합성된다.Melanin is tyrosine in melanocytes (tyrosine) as a substrate to act as a tyrosinase (tyrosinase) to produce a dopaquinone (dopaquinone) is synthesized through the oxidation and enzyme reaction.

따라서, 인체 피부에 멜라닌의 합성을 억제하기 위해서는 타이로시나제의 활성을 억제시키거나, 멜라닌 생성과정 중의 일부반응을 억제하는 효과가 있는 물질이 필요한데, 타이로시나제 저해제(tyrosinase inhibitor)로 아스코빈산(ascorbic acid), 코티코스테로이드(corticosteroids), 레티노이드(retinoids) 아제락산 (azelaic acid), 하이드로퀴논(hydroquinone), 하이드록시아니솔(hydroxyanisole), 코지산(kojic acid), 아부틴(arbutin) 등이 있으나, 이러한 화학합성 물질은 안전성, 안정성 및 장기보관시 변색, 변취 등과 같은 문제점이 있었다.Therefore, in order to inhibit the synthesis of melanin in the human skin, a substance having an effect of inhibiting the activity of tyrosinase or inhibiting some reactions during the production of melanin is required. As a tyrosinase inhibitor, Ascorbic acid, corticosteroids, retinoids, azelaic acid, hydroquinone, hydroxyanisole, kojic acid, arbutin, etc. However, these chemical synthetic materials have problems such as safety, stability and discoloration and deodorization during long-term storage.

상기와 같은 문제점을 극복하기 위하여 천연물질인 식물의 추출물을 미백성분으로 활용하기 위한 연구가 지속적으로 이루어져 왔는데, 이와 관련한 공지기술로는 상백피의 성분을 이용한 미백화장료(한국공개특허 제92-2109호, 일본공개특허 소화 제 55-44375호, 일본공개특허 소화 제64-26507호, 일본공개특허 소화 제64-83009호, 일본공개특허 평성 제1-256587호), 감초의 성분을 이용한 미백화장료(한국공개특허 제92-2109호, 일본공개특허 소화 제60-214721호, 일본공개특허 소화 제63-23809호, 일본공개특허 평성 제1-149706호) 등이 개시되어 있다.In order to overcome the above problems, research has been continuously conducted to utilize the extracts of plants, which are natural substances, as a whitening ingredient. As a well-known technique, the whitening cosmetics using the ingredients of baekbaekpi (Korean Patent Publication No. 92-2109) , Japanese Patent Application No. 55-44375, Japanese Patent Application No. 64-26507, Japanese Patent Application No. 64-83009, Japanese Patent Application Publication No. 1-256587), Whitening cosmetics using ingredients of licorice ( Korean Patent Application Publication No. 92-2109, Japanese Patent Application Publication No. 60-214721, Japanese Patent Application Publication No. 63-23809, Japanese Patent Application Publication No. Hei 1-49706), and the like.

또한, 작약의 성분을 이용한 미백화장료(일본공개특허 소화 제61-246109호), 계피의 성분을 이용한 미백화장료(일본공개특허 소화 제63-30403호), 치자열매 추출물을 이용한 미백조성물(한국공개특허 제2002-4896호), 유근피 추출물을 함유하는 항노화 화장품 조성 (한국공개특허 제2002-4896호), 천련자 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93861호), 파고지 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93859호) 및 오수유 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93860호) 등이 개시되어 있다.Also, whitening cosmetics using ingredients of peony (Japanese Patent Laid-Open No. 61-246109), whitening cosmetics using ingredients of cinnamon (Japanese Laid-Open Patent No. 63-30403), and whitening compositions using gardenia berry extract (Korean publication) Patent No. 2002-4896), anti-aging cosmetic composition containing the extract of Yu-geun-pi (Korea Patent Publication No. 2002-4896), whitening composition containing Cheonnyeonja extract (Korean Patent No. 2001-93861), pagoji extract A whitening composition (Korean Patent Publication No. 2001-93859) and a whitening composition (Korean Patent Publication No. 2001-93860) containing a sewage extract are disclosed.

상기와 같은 다수의 식물추출물이 타이로시나제에 작용하여 멜라닌의 합성을 억제한다는 사실이 밝혀졌으나, 이와 같은 천연성분도 강한 저해활성을 유지하면서 안전성, 안정성 및 변색 가능성 등의 문제를 완전히 해결하기에는 미흡한 실정이다.It has been found that many of the above plant extracts act on tyrosinase to inhibit melanin synthesis, but such natural ingredients are insufficient to completely solve problems such as safety, stability, and discoloration potential while maintaining strong inhibitory activity. It is true.

이에 본 발명자들은 상기와 같은 문제점을 해결하기 위한 연구를 수행하여 천연소재인 쑥갓추출물을 이용하여 안정성을 유지하면서 멜라닌세포의 증식억제 및 멜라닌의 생성에 관여하는 타이로시나제의 활성을 억제하여 멜라닌의 생성량을 감소시킬 수 있는 미백조성물을 제조할 수 있음을 알아내고 본 발명을 완성하였다.Therefore, the present inventors conducted a study to solve the above problems by maintaining the stability using the wormwood extract, a natural material while inhibiting the activity of tyrosinase involved in the inhibition of melanocyte proliferation and the production of melanin to melanin The present invention was completed by finding out that a whitening composition capable of reducing the amount of produced was prepared.

따라서, 본 발명의 목적은 쑥갓추출물을 유효성분으로 함유하는 새로운 미백조성물을 제공함에 있다.Accordingly, it is an object of the present invention to provide a new whitening composition containing the mugwort extract as an active ingredient.

도 1 은 본 발명에 의한 쑥갓추출물의 멜라닌세포 증식억제 효과,1 is a melanocyte proliferation inhibitory effect of mugwort extract according to the present invention,

도 2 는 본 발명에 의한 쑥갓추출물의 도파 옥시다제 활성 억제효과,2 is an effect of inhibiting the dopa oxidase activity of mugwort extract according to the present invention,

도 3 은 본 발명에 의한 쑥갓추출물의 멜라닌생성 억제효과,3 is a melanin production inhibitory effect of mugwort extract according to the present invention,

도 4 는 본 발명에 의한 쑥갓 에탄올추출물 1000㎍/㎖ 처리 3일 후 B16 멜라노마 세포의 형태를 나타낸 것이다.Figure 4 shows the morphology of B16 melanoma cells three days after treatment with 1000 ㎍ / ㎖ ethanol extract according to the present invention.

쑥갓(crown daisy)의 전초에는 항산화 효과를 나타내는 플라보노이드(flavonoid) 계열의 유도체 성분이 많이 발견되고 있는데, 그 성분들로는 카페인산(caffeic acid), 클로로지닌산(chlorogenic acid), 3,5-디카페오일퀴닌산(3,5-dicaffeoylquinic acid), 4-썩니닐-3,5-디카페오닐퀴닌산(4-succinyl-3,5-dicaffeoylquinic acid), 에모딘(emodin), 티오펜(N-이소부틸-6(2-티오페닐)-2,4-헥사디엔아미드-1,8-디하이드록시앤쓰로퀴논(thiophene(N-isobutyl-6-(2-thiophenyl)-2,4-hexadienamide-1,8-dihydroxyanthroquinone), 쿼세틴(quercetin) 및 그 글리코사이드 유도체(glycoside derivatives), 루틴(rutin) 및 이소쿼세틴(isoquercetin) 등이 알려져 있다.In the outposts of wormwood (crown daisy), many flavonoid derivatives have antioxidant properties, including caffeic acid, chlorogenic acid, and 3,5-dicafee. Oilquinic acid (3,5-dicaffeoylquinic acid), 4-reninyl-3,5-dicafeonylquinic acid (4-succinyl-3,5-dicaffeoylquinic acid), emodin, thiophene (N- Isobutyl-6 (2-thiophenyl) -2,4-hexadieneamide-1,8-dihydroxyandthroquinone (thiophene (N-isobutyl-6- (2-thiophenyl) -2,4-hexadienamide- 1,8-dihydroxyanthroquinone, quercetin and its glycoside derivatives, rutin and isoquercetin are known.

쑥갓에 함유되어 있는 비타민 C, 카로티노이드(carotinoid) 및 그 외 풍부한 항산화 성분들은 심장혈관계 질병을 예방하고, 크리산코린(chrysancorin)은 항균 작용이 있는 것으로 보고되고 있다(Takenaka M. et al., M. Stability andbioavailability of antioxidants in garland (Chrysanthemum coronarium L.)Biosci Biotechnol Biochem. 2000 Dec;64(12):2689-91 ; Gins V.K. et al., Oxyanthraquinones and flavonoids from garland chrysanthenumPrikl Biokhim Mikrobiol. 2000 May-Jun;36(3):344-53 ; Wang H. et al., Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seedsBiol Chem. 2001 Jun;382(6):947-51).Vitamin C, carotinoids and other rich antioxidants in wormwood are known to prevent cardiovascular diseases, and chrysancorin has been reported to have antimicrobial activity (Takenaka M. et al., M Stability and bioavailability of antioxidants in garland (Chrysanthemum coronarium L.) Biosci Biotechnol Biochem . 2000 Dec; 64 (12): 2689-91; Gins VK et al., Oxyanthraquinones and flavonoids from garland chrysanthenum Prikl Biokhim Mikrobiol . 2000 May-Jun; 36 (3): 344-53; Wang H. et al., Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seeds Biol Chem . 2001 Jun; 382 (6): 947-51).

본 발명에 의한 미백조성물에는 쑥갓의 동결건조 추출물, 쑥갓의 열수 추출물 및 쑥갓의 에탄올 추출물로 구성된 군에서 선택된 1종 또는 2종 이상의 쑥갓추출물이 사용된다.In the whitening composition according to the present invention, one or two or more wormwood extracts selected from the group consisting of lyophilized extract of mugwort, hot water extract of mugwort, and ethanol extract of mugwort are used.

본 발명에 사용되는 쑥갓의 동결건조 추출물(crude extracts)은 믹서 또는 균질기(homogenizer)에 넣어 잘게 간 쑥갓을 냉동고(deep freezer)에서 오버나잇(overnight)시킨 후 냉동건조기(freeze dryer)로 2-3일 동안 완전히 건조시켜 제조한다.The freeze-dried extracts of mugwort used in the present invention are added to a mixer or homogenizer, and then overnight in a deep freezer. Prepare by drying completely for 3 days.

본 발명에 사용되는 쑥갓의 열수추출물(water soluble extracts)은 완전히 건조된 쑥갓에 증류수를 첨가하고 열수중탕으로 4-6시간 추출하여 여과한 추출물을 냉동고에서 오버나잇시킨 후, 냉동건조기에서 2-3일 동안 건조시켜 제조한다.The water soluble extracts of mugwort used in the present invention are added to distilled water to completely dried mugwort and extracted with hot water bath for 4-6 hours, after the filtered extract is overnight in a freezer, 2-3 in a freeze dryer. Prepared by drying for days.

또한, 본 발명에 사용되는 쑥갓의 에탄올 추출물(ethanol soluble extracts)은 완전히 건조된 쑥갓에 에탄올을 첨가하고 45-55℃에서 4-6시간 추출하여 여과한 추출물을 냉동고에서 오버나잇시킨 후 냉동건조기에서 2-3일 동안 완전히 건조시켜 제조한다.In addition, ethanol soluble extracts of wormwood used in the present invention (ethanol soluble extracts) is added to the ethanol to completely dried mugwort and extracted for 4-6 hours at 45-55 ℃ over night the filtered extract in the freezer and then in a freeze dryer Prepare by drying completely for 2-3 days.

본 발명에서는 세포증식 실험, 타이로시나제 활성실험, 멜라닌양 측정실험 등을 통해 상기에서 제조한 쑥갓추출물이 멜라닌세포에 미치는 영향을 검증하였는데, 본 발명에 사용된 쑥갓추출물이 멜라닌세포의 증식을 억제하고, 멜라닌의 생성에 관여하는 티로시나제의 활성을 억제시킬 뿐만 아니라 멜라닌양을 감소시킴을 관찰함으로써 미백효과가 있음을 확인할 수 있었다.In the present invention, the effects of the above-mentioned mugwort extracts on melanocytes were verified through cell proliferation experiments, tyrosinase activity experiments, melanin amount measurement experiments, and the mugwort extracts used in the present invention were used for the proliferation of melanocytes. By inhibiting and inhibiting the activity of tyrosinase involved in the production of melanin as well as reducing the amount of melanin, it was confirmed that there is a whitening effect.

본 발명에 의한 미백조성물은 상기의 쑥갓추출물을 0.01-10 중량%, 바람직하게는 0.01-5 중량% 함유하는데, 쑥갓추출물을 0.01 중량% 이하를 함유하면 미백효과가 없고, 10 중량% 이상을 함유하면 안전성 또는 제형상의 조제에 문제가 생길 수 있기 때문이다.The whitening composition according to the present invention contains 0.01-10% by weight, preferably 0.01-5% by weight of the mugwort extract, but if it contains 0.01% by weight or less of mugwort extract, it does not have a whitening effect and contains 10% by weight or more. This is because there may be a problem in the safety or formulation formulation.

본 발명에 의한 미백조성물은 화장용 크림, 화장수, 화장용 유액, 미용수 등과 같은 화장료나 액상 및 고상의 비누 또는 시럽제, 연고, 크림제제, 전제, 틴크제, 엑기스제, 한방제제, 침제, 전제 등과 같은 내복 또는 외용의 제제로 조제될 수 있는데, 미백효과를 증진시키기 위하여 피부흡수 촉진물질을 함유할 수 있다.The whitening composition according to the present invention may be used in cosmetics such as cosmetic creams, lotions, cosmetic emulsions, beauty waters, liquid or solid soaps or syrups, ointments, creams, premises, tinctures, extracts, herbal preparations, acupuncture agents, premises It may be formulated as an oral or external preparation, and may contain a skin absorption promoting substance to enhance the whitening effect.

이하 본 발명을 실시예 및 시험예를 통하여 보다 상세히 설명한다. 그러나 본 발명의 기술적 범위가 이들 실시예 및 시험예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples. However, the technical scope of the present invention is not limited to these examples and test examples.

<실시예 1> (쑥갓 동결건조 추출물의 제조)<Example 1> (Preparation of mugwort lyophilized extract)

물에 씻어 깨끗하게 준비된 쑥갓 1kg을 균질기에 넣어 고르게 균질화한 후, -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 동결건조 추출물 18.923g을 제조하였다.1kg of wormwood freshly prepared by washing in water was homogenized evenly in a homogenizer, and then overnight overnight in a -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 1 day 23g freeze-dried extract Was prepared.

<실시예 2> (쑥갓 열수추출물의 제조)<Example 2> (Preparation of mugwort hot water extract)

실시예 1에서 제조한 완전히 건조된 쑥갓 동결건조 추출물 5g에 100ml의 증류수를 첨가하고 80℃에서 열수중탕으로 5시간 동안 추출하였다.100 ml of distilled water was added to 5 g of the dried dried mugwort lyophilized extract prepared in Example 1, and extracted with hot water bath at 80 ° C. for 5 hours.

상기에서 얻은 추출물을 화트만(Whatman) No.2 여과지로 여과한 추출물을 -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음, 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 열수추출물 44.75mg(8.951g/쑥갓1kg)을 제조하였다.The extract obtained above was filtered through Whatman No. 2 filter paper overnight at -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 3 days. 44.75 mg (8.951 g / wormwood 1 kg) extract was prepared.

<실시예 3> (쑥갓 에탄올 추출물의 제조)<Example 3> (Preparation of mugwort ethanol extract)

실시예 1에서 제조한 완전히 건조된 쑥갓 동결건조 추출물 5g에 100ml의 70% 에탄올을 첨가하고 50℃에서 5시간 동안 추출하였다.100 g of 70% ethanol was added to 5 g of the fully dried mugwort lyophilized extract prepared in Example 1, and extracted at 50 ° C. for 5 hours.

상기에서 얻은 추출물을 광목으로 여과한 추출물을 -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음, 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 에탄올 추출물 10.78mg (2.157g/쑥갓1kg)을 제조하였다.The extract obtained by filtering the extract obtained above with a tree was overnight overnight in a -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 3 days, and 10.78mg of ethanol extract (2.157g / wormwood) 1 kg) was prepared.

<실시예 4> (쑥갓추출물을 함유하는 영양화장수의 제조)Example 4 (Preparation of Nutrients Containing Mugwort Extract)

실시예 2에서 제조한 쑥갓 열수추출물 5 중량부, 밀납 5 중량부, 폴리솔베이트 60 1 중량부, 솔비탄세스퀴올레이드 0.5 중량부, 유동파라핀 3 중량부, 스쿠알란 3 중량부, 카프릭트리글리세라이드 3 중량부, 글리세린 2.5 중량부, 부틸렌글리콜 2.5 중량부, 프로필렌글리콜 2.5 중량부, 카르복시비닐폴리머 0.1 중량부, 트리에탄올 아민 0.1 중량부와 적량의 방부제, 색소, 향료 및 정제수를 이용하여 통상의 방법으로 영양화장수를 제조하였다.5 parts by weight of mugwort hot water extract prepared in Example 2, 5 parts by weight of beeswax, 1 part by weight of polysorbate 60, 0.5 parts by weight of sorbitassesquiolade, 3 parts by weight of liquid paraffin, 3 parts by weight of squalane, capric triglyceride 3 parts by weight, glycerin 2.5 parts by weight, butylene glycol 2.5 parts by weight, propylene glycol 2.5 parts by weight, 0.1 parts by weight of carboxyvinyl polymer, 0.1 parts by weight of triethanol amine and a suitable amount of preservatives, pigments, flavors and purified water The nutritional cosmetics were prepared.

<실시예 5> (쑥갓추출물을 함유하는 크림의 제조)Example 5 Preparation of Cream Containing Mugwort Extract

실시예 3에서 제조한 쑥갓 에탄올추출물 10중량부, 스테아릴 알콜 8 중량부, 스테아린산 2 중량부, 스테아린산 콜레스테롤 2 중량부, 스쿠알란 4 중량부, 2-옥틸도데실알콜 6 중량부, 폴리옥시에틸렌알콜 에스테르 3중량부, 글리세릴 모노스테아린산 에스텔 2 중량부, 프로필렌글리콜 5 중량부 및 정제수를 이용하여 통상의 방법으로 크림을 제조하였다.10 parts by weight of wormwood ethanol extract prepared in Example 3, 8 parts by weight of stearyl alcohol, 2 parts by weight of stearic acid, 2 parts by weight of stearic acid cholesterol, 4 parts by weight of squalane, 6 parts by weight of 2-octyldodecyl alcohol, polyoxyethylene alcohol Cream was prepared by the conventional method using 3 weight part of esters, 2 weight part of glyceryl monostearic acid esters, 5 weight part of propylene glycol, and purified water.

<시험예 1> (B16 멜라노마 세포배양)<Test Example 1> (B16 melanoma cell culture)

본 발명에 의한 미백조성물에 사용된 쑥갓 추출물의 세포증식, 타이로시나제 활성 및 멜라닌양 측정에 이용되는 B16 멜라노마 세포(B16 melanoma cell)를 RPMI1640 기본배지에 10% 소태아혈청(fetal bovine serum), 1% 페니실닌-스트렙토마이신(penicillin-streptomycin)을 첨가한 배지로 37℃, 5% CO2의 조건에서 배양하였는데, 배양중의 배지는 3일에 한번씩 갈아주었다.B16 melanoma cells used for cell proliferation, tyrosinase activity, and melanin levels of wormwood extracts used in the whitening composition according to the present invention, 10% fetal bovine serum (fetal bovine serum) in RPMI1640 basic medium 1% penicillin-streptomycin was added to the culture medium at 37 ° C. and 5% CO 2. The culture medium was changed every three days.

<시험예 2> (세포증식 억제효과 측정)Test Example 2 (Measurement of Cell Proliferation Inhibition Effect)

본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 멜라닌 세포증식 억제효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE)을 처리한 B16 멜라노마 세포의 증식율을 측정한 결과를 표 1 및 도 1에 나타내었다.Mugwort freeze-dried extract (CE), mugwort hot water extract (WE) and mugwort hot water extract (WE) prepared in Examples 1 to 3 in order to determine the melanin cell growth inhibition effect of mugwort extract used in the whitening composition according to the present invention The results of measuring the proliferation rate of B16 melanoma cells treated with EE) are shown in Table 1 and FIG. 1.

세포증식율은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을 처리하여 세포를 수확하였다.Cell proliferation was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day.

수확된 세포진탕액 중 500㎕를 떠서 이소톤용액(isotone solution) 10 ㎖과 균일하게 혼합한 후 카울터 계수기(coulter counter ; ZM, Coulter Co., England)로 세포수를 세었는데, 총세포수의 계산은 다음과 같이 하였다.500 μl of the harvested cell shaker was mixed and uniformly mixed with 10 ml of isotone solution and counted with a Coulter counter (ZM, Coulter Co., England). The calculation was as follows.

총세포수 = 카울터 계수기가 센 세포수 X 42 X (세포 진탕액양/ ㎖)Total cell count = number of cells counted by the Coulter counter x 42 X (cell shake amount / ml)

<표 1> 세포증식율TABLE 1 Cell Proliferation Rate

구 분division 농 도Concentration 10 ㎍/㎖10 μg / ml 100 ㎍/㎖100 μg / ml 1000 ㎍/㎖1000 μg / ml CECE 98%98% 92%92% 59%59% WEWE 102%102% 100%100% 71%71% EEEE 99%99% 96%96% 69%69%

상기 표 1 및 도 1에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 멜라닌세포 증식억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 멜라닌세포 증식억제율이 높음을 알 수 있다.As shown in Table 1 and Figure 1, the wormwood extract 10 ㎍ / ㎖ and 100 ㎍ / ㎖ treated with a low melanocyte proliferation inhibition rate, 1000 ㎍ / ㎖ treated lyophilized extract (CE), mugwort hot water extract (WE) And wormwood ethanol extract (EE) both can be seen that the melanocyte proliferation inhibition rate is high.

<시험예 3> (도파 옥시다제 활성 억제효과 측정)<Test Example 3> (Measurement of Dopa Oxidase Activity Inhibition Effect)

본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 미백효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 처리에 의한 멜라닌 생성과정 중 도파에서 도파퀴논으로 전환될 때 관여하는 도파 옥시다제(dopa-oxidase)의 활성억제율을 측정한 결과를 표 2 및 도 2에 나타내었다.Mugwort lyophilized extract (CE), mugwort hot water extract (WE) and mugwort ethanol extract (EE) prepared in Examples 1 to 3 to investigate the whitening effect of mugwort extract used in the whitening composition according to the present invention Table 2 and FIG. 2 show the results of measuring the activity inhibition rate of dopa-oxidase involved in the conversion of dopaquinone to dopaquinone during melanin production.

도파 옥시다제의 활성억제율은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을 처리하여 세포를 수확하여 카울터 계수기로 세포수를 세었다.The activity inhibition rate of dopa oxidase was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day and counted with a Coulter counter.

그런 다음 처리군당 2X105세포를 1.7ml 튜브에 각각 나누어 담고 여기에 1mM L-도파(Sigma Chemical Co., St, Louis, Missouri)가 함유된 세포분쇄용액 100㎕를 첨가하고 1시간 동안 37℃에서 반응시킨 후 분광광도계로 490nm에서 흡광도를측정하였다.Then, divide 2X10 5 cells per treatment group into 1.7 ml tubes, add 100 μl of 1 mM L-dopa (Sigma Chemical Co., St, Louis, Missouri), and then dissolve the cell grinding solution at 37 ° C. for 1 hour. After the reaction, the absorbance was measured at 490 nm with a spectrophotometer.

<표 2> 도파 옥시다제 활성TABLE 2 Dopa Oxidase Activity

구 분division 농 도Concentration 10 ㎍/㎖10 μg / ml 100 ㎍/㎖100 μg / ml 1000 ㎍/㎖1000 μg / ml CECE 88%88% 75%75% 36%36% WEWE 97%97% 81%81% 39%39% EEEE 90%90% 78%78% 37%37%

상기 표 2 및 도 2에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 도파 옥시다제의 활성억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 도파 옥시다제 활성억제율이 높음을 알 수 있다.As shown in Table 2 and FIG. 2, the activity inhibition rate of dopa oxidase was low in the 10 ㎍ / ml and 100 ㎍ / ml treatment of mugwort extract, but the freeze-dried extract (CE) and mugwort hot water extract ( Both WE) and wormwood ethanol extract (EE) showed high dopa oxidase activity inhibition rate.

<시험예 4> (멜라닌 생성량 측정)<Test Example 4> (Melanin production amount measurement)

본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 미백효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 처리에 의한 멜라닌생성량을 측정한 결과를 표 3 및 도 3에 나타내었다.Mugwort lyophilized extract (CE), mugwort hot water extract (WE) and mugwort ethanol extract (EE) prepared in Examples 1 to 3 to investigate the whitening effect of mugwort extract used in the whitening composition according to the present invention The results of measuring the amount of melanin production by are shown in Table 3 and FIG.

멜라닌 생성량은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을처리하여 세포를 수확하여 카울터 계수기로 세포수를 세었다.Melanin production was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day and counted with a Coulter counter.

그런 다음 각 처리군별로 2X105세포수 당 100㎕의 1N NaOH 용액을 넣고 37℃에서 12시간 동안 세포를 용해시킨 후, 완전히 용해된 샘플의 흡광도를 측정하기 전에 합성멜라닌(Sigma. Chemical Co., St, Louis, Misso) 10mg을 1N NaOH 10㎖에 용해시켜 스탁용액(stock solution) 1mg/㎖을 제조한 뒤 700g/㎖, 300g/㎖, 100g/㎖, 70g/㎖, 30g/㎖, 10g/㎖, 7g/㎖, 3g/㎖, 1g/㎖, 0.1g/㎖ 및 0g/㎖ 농도로 희석하여 표준용액(standard solution)을 제조하였다.Then, 100 μl of 1N NaOH solution per 2 × 10 5 cell number was added to each treatment group, and the cells were lysed at 37 ° C. for 12 hours, and then synthetic melanin (Sigma. Chemical Co., St, Louis, Misso) 10mg dissolved in 10ml of 1N NaOH to prepare 1mg / ml of stock solution, 700g / ml, 300g / ml, 100g / ml, 70g / ml, 30g / ml, 10g / A standard solution was prepared by diluting to ml, 7g / ml, 3g / ml, 1g / ml, 0.1g / ml and 0g / ml.

샘플과 표준용액을 96 웰검정판(well assy plate)에 넣고 490nm에서 분광광도계로 흡광도를 측정한 다음, 측정된 흡광도값을 합성 멜라닌으로 작성된 표준직선에 적용하여 멜라닌량으로 환산하였다.The sample and the standard solution were placed in a 96 well assy plate, and the absorbance was measured with a spectrophotometer at 490 nm, and then the measured absorbance value was applied to a standard straight line made of synthetic melanin, and converted into melanin amount.

<표 3> 멜라닌 생성량Table 3 Melanin Production

구 분division 농 도Concentration 10 ㎍/㎖10 μg / ml 100 ㎍/㎖100 μg / ml 1000 ㎍/㎖1000 μg / ml CECE 91%91% 78%78% 27%27% WEWE 99%99% 85%85% 35%35% EEEE 99%99% 82%82% 26%26%

상기 표 3 및 도 3에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 멜라닌 생성억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 멜라닌 생성억제율이 높음을 알 수 있다.As shown in Table 3 and FIG. 3, the melanin production inhibition rate was low in the 10 ㎍ / ㎖ and 100 ㎍ / ㎖ treatment mugwort extract, but lyophilized extract (CE), mugwort hot water extract (WE) and 1000 ㎍ / ㎖ treatment It can be seen that wormwood ethanol extract (EE) has a high melanin production inhibition rate.

<시험예 5> (안정성 시험)<Test Example 5> (stability test)

본 발명에 의한 쑥갓추출물을 함유하는 미백조성물의 안정성을 시험하기 위하여 실시예 4에서 제조한 영양화장수 및 실시예 5에서 제조한 크림을 4℃, 상온(25℃), 40℃ 및 50℃에서 3개월 동안 방치시킨 후, 각 조성물의 안정성을 관찰한 결과를 표 4에 나타내었다.In order to test the stability of the whitening composition containing wormwood extract according to the present invention, the nutrient lotion prepared in Example 4 and the cream prepared in Example 5 were used at 4 ° C, room temperature (25 ° C), 40 ° C and 50 ° C. After being left for months, the results of observing the stability of each composition are shown in Table 4.

<표 4>. 안정성 시험결과TABLE 4 Stability Test Results

구 분division 보 관 온 도 (℃)Storage temperature (℃) 44 2525 4040 5050 실시예 4Example 4 안정stability 안정stability 안정stability 안정stability 실시예 5Example 5 안정stability 안정stability 안정stability 안정stability

상기 표 4에서 보는 바와 같이, 본 발명에 의한 미백조성물은 장시간 경과 후에도 안정성을 유지함을 알 수 있다.As shown in Table 4, it can be seen that the whitening composition according to the present invention maintains stability even after a long time.

본 발명에 의한 미백조성물은 천연소재인 쑥갓추출물을 함유하고 있어 멜라닌세포의 증식억제 및 멜라닌의 생성에 관여하는 타이로시나제의 활성을 억제하여 멜라닌의 생성량을 감소시킴으로써 미백효과를 갖음과 동시에 장시간 보관시에도 안정성을 유지할 수 있다.The whitening composition according to the present invention contains wormwood extract, which is a natural material, has a whitening effect by reducing the amount of melanin by inhibiting the activity of tyrosinase involved in the proliferation of melanocytes and the production of melanin. Stability can be maintained even during storage.

Claims (3)

쑥갓 추출물을 유효성분으로 함유하는 미백조성물Whitening composition containing mugwort extract as active ingredient 제 1 항에 있어서,The method of claim 1, 상기 조성물은 쑥갓 추출물을 0.01-10 중량% 함유함을 특징으로 하는 미백조성물The composition is a whitening composition characterized in that it contains 0.01-10% by weight of wormwood extract 제 1 항 또는 제 2 항에 있어서,The method according to claim 1 or 2, 상기 쑥갓 추출물은 쑥갓의 동결건조 추출물, 쑥갓의 열수 추출물 및 쑥갓의 에탄올 추출물로 구성된 군에서 선택된 1종 또는 2종 이상임을 특징으로 하는 미백조성물The mugwort extract is a whitening composition characterized in that one or two or more selected from the group consisting of lyophilized extract of mugwort, hot water extract of mugwort, and ethanol extract of mugwort
KR1020020025045A 2002-05-07 2002-05-07 A composition for whitening containing crown daisy extract KR20030086849A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020025045A KR20030086849A (en) 2002-05-07 2002-05-07 A composition for whitening containing crown daisy extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020025045A KR20030086849A (en) 2002-05-07 2002-05-07 A composition for whitening containing crown daisy extract

Publications (1)

Publication Number Publication Date
KR20030086849A true KR20030086849A (en) 2003-11-12

Family

ID=32381844

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020025045A KR20030086849A (en) 2002-05-07 2002-05-07 A composition for whitening containing crown daisy extract

Country Status (1)

Country Link
KR (1) KR20030086849A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100896520B1 (en) * 2007-12-03 2009-05-08 행복의샘 (주) Mulberry juice containing baekbaekpi and its manufacturing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135803A (en) * 1982-02-05 1983-08-12 Noriko Sugano Preparation of nutrient beauty lotion
WO1999013856A1 (en) * 1997-09-18 1999-03-25 L'oreal Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation
KR101094278B1 (en) * 2010-03-09 2011-12-19 삼성모바일디스플레이주식회사 Organic light emitting display
KR101102340B1 (en) * 2010-03-23 2012-01-03 한국과학기술원 3D inductor

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135803A (en) * 1982-02-05 1983-08-12 Noriko Sugano Preparation of nutrient beauty lotion
WO1999013856A1 (en) * 1997-09-18 1999-03-25 L'oreal Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation
KR101094278B1 (en) * 2010-03-09 2011-12-19 삼성모바일디스플레이주식회사 Organic light emitting display
KR101102340B1 (en) * 2010-03-23 2012-01-03 한국과학기술원 3D inductor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100896520B1 (en) * 2007-12-03 2009-05-08 행복의샘 (주) Mulberry juice containing baekbaekpi and its manufacturing method

Similar Documents

Publication Publication Date Title
KR101971837B1 (en) Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component
KR20170132388A (en) Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata
KR102594733B1 (en) Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof
KR20200138870A (en) Composition for preventing or improving skin aging comprising an extract of rhodiola sachalinesis fermented by bovista plumbea
CN113631227B (en) Anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and cosmetics
KR101071414B1 (en) Whitening composition containing guanavana extract as an active ingredient
KR102489463B1 (en) Composition for whitening comprising extract of microwave treated Dendropanax morbifera
KR101295336B1 (en) A Cosmetic Composition Comprising Fagopyrum Tataricum Extract And Preparing Method Thereof
KR102471009B1 (en) Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles
KR20030085771A (en) A composition for whitening containing dropwort extract
KR102154139B1 (en) Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract
KR102006665B1 (en) Anti-oxidant, anti-inflammatory, whitening and moisturizing cosmetic composition comprising the mixed herbal extract of silver weed, heather, and milk thistle as an active ingredient and preparation method of the same
KR20030086849A (en) A composition for whitening containing crown daisy extract
KR20230079615A (en) Liposome comprsings barley sprout extract and vitamin tree fruit extract and cosmetic compositions containing the same
KR20030090126A (en) A composition for whitening containing fruit of Chinese quince extract
KR20040076103A (en) Method of producing a cosmetic composition which contains mixed plant extracts
KR20190063600A (en) Composition for skin whitening comprising extract of stichopus japonicas red
KR102356144B1 (en) Cosmetic composition and health functional food for skin whitening and anti-wrinkle
KR102702220B1 (en) Codonopsis lanceolata and Making method of the same
KR102374884B1 (en) Cosmetic composition containing the extract of dendropanax morbifera and wild ginseng as active ingredient
KR101068808B1 (en) Composition for Whitening Containing Extract of Delonix regia
KR101079713B1 (en) Composition for Whitening Containing Extract of Talinum crassifolium as an active ingredient
KR20010025288A (en) Protocatechuic aldehyde as a tyrosinase inhibitor and herb extract containing the compound
KR20030005721A (en) A cosmetic composition containing an extract of trichosanthes kirilowii
KR101791425B1 (en) Cosmetic composition for skin-whitening comprising mixture extract of Coptis chinensis, EVODIA RUTAECARPA and Paeonia lactiflora P.

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20020507

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20040730

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20041025

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20040730

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I